Lucidone from Lindera erythrocarpa Makino fruits suppresses adipogenesis in 3T3-L1 cells and attenuates obesity and consequent metabolic disorders in high-fat diet C57BL/6 mice

Phytomedicine

Volumn 20, Issue 5, 2013, Pages 394-400

  Hsieh, Yu Hsin ^a   Wang, Sheng Yang ^a,b  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b AGRICULTURAL BIOTECHNOLOGY RESEARCH CENTER   (Taiwan)

Author keywords

Adipogenesis; High fat diet; Lindera erythrocarpa; Lucidone; Obesity

Indexed keywords

ADIPONECTIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; LIPOPROTEIN LIPASE; LUCIDONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLANT MEDICINAL PRODUCT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; EPIDIDYMIS FAT; FRUIT; GENE EXPRESSION; GENETIC TRANSCRIPTION; GLUCOSE BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; INSULIN BLOOD LEVEL; LINDERA; LINDERA ERYTHROCARPA; LIPID DIET; LIVER WEIGHT; MALE; MEDICINAL PLANT; METABOLIC DISORDER; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; WEIGHT GAIN;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ADIPOSE TISSUE; ANIMALS; ANTI-OBESITY AGENTS; CELL COUNT; CYCLOPENTANES; DIET, HIGH-FAT; DOSE-RESPONSE RELATIONSHIP, DRUG; FRUIT; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORTER TYPE 4; LINDERA; LIVER; MALE; MICE; MICE, INBRED C57BL; OBESITY; ORGAN SIZE; ORPHAN NUCLEAR RECEPTORS; PHYTOTHERAPY; PPAR GAMMA; TRANSCRIPTION, GENETIC;

LINDERA ERYTHROCARPA; MUS;

EID: 84875226487     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2012.11.007     Document Type: Article

References (24)

1. M.M. Avram, A.S. Avram, and W.D. James Subcutaneous fat in normal and diseased states 3. Adipogenesis: from stem cell to fat cell Journal of the American Academy of Dermatology 56 2007 472 492
2. M. Bose, J.D. Lambert, J. Ju, K.R. Reuhl, S.A. Shapses, and C.S. Yang The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice The Journal of Nutrition 138 2008 1677 1683
3. Z. Cao, R.M. Umek, and S.L. McKnight Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells Genes and Development 5 1991 1538 1552
4. B.H. Choi, I.S. Ahn, Y.H. Kim, J.W. Park, S.Y. Lee, C.K. Hyun, and M.S. Do Berberine reduces the expression of adipogenic enzymes and inflammatory molecules of 3T3-L1 adipocyte Experimental and Molecular Medicine 38 2006 599 605
5. A. Ejaz, D. Wu, P. Kwan, and M. Meydani Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice The Journal of Nutrition 139 2009 919 925
6. H. Green, and O. Kehinde An established preadipose cell line and its differentiation in culture II. Factors affecting the adipose conversion Cell 5 1975 19 27
7. F.M. Gregoire Adipocyte differentiation: from fibroblast to endocrine cell Experimental Biology and Medicine 226 2001 997 1002
8. W. He, Y. Barak, A. Hevener, P. Olson, D. Liao, J. Le, M. Nelson, E. Ong, J.M. Olefsky, and R.M. Evans Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle Proceedings of the National Academy of Sciences of the United States of America 100 2003 15712 15717
9. Y. Hu, E.A. Ehli, J. Kittelsrud, P.J. Ronan, K. Munger, T. Downey, K. Bohlen, L. Callahan, V. Munson, M. Jahnke, L.L. Marshall, K. Nelson, P. Huizenga, R. Hansen, T.J. Soundy, and G.E. Davies Lipid-lowering effect of berberine in human subjects and rats Phytomedicine 19 2012 861 867
10. C. Huang, Y. Zhang, Z. Gong, X. Sheng, Z. Li, W. Zhang, and Y. Qin Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARgamma pathway Biochemical and Biophysical Research Communications 348 2006 571 578
11. J.T. Hwang, I.J. Park, J.I. Shin, Y.K. Lee, S.K. Lee, H.W. Baik, J. Ha, and O.J. Park Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase Biochemical and Biophysical Research Communications 338 2005 694 699
12. K.P. Keenan, G.C. Ballam, R. Dixit, K.A. Soper, P. Laroque, B.A. Mattson, S.P. Adams, and J.B. Coleman The effects of diet, overfeeding and moderate dietary restriction on Sprague-Dawley rat survival, disease and toxicology The Journal of Nutrition 127 1997 851S 856S
13. K.J. Kumar, and S.Y. Wang Lucidone inhibits iNOS and COX-2 expression in LPS-induced RAW 264.7 murine macrophage cells via NF-kappaB and MAPKs signaling pathways Planta Medica 75 2009 494 500
14. J. Lin, M.A. Della-Fera, and C.A. Baile Green tea polyphenol epigallocatechin gallate inhibits adipogenesis and induces apoptosis in 3T3-L1 adipocytes Obesity Research 13 2005 982 990
15. A.R. Nawrocki, and P.E. Scherer Keynote review: the adipocyte as a drug discovery target Drug Discovery Today 10 2005 1219 1230
16. J.M. Ntambi, and K. Young-Cheul Adipocyte differentiation and gene expression The Journal of Nutrition 130 2000 3122S 3126S
17. K.J. Senthil Kumar, H.W. Hsieh, and S.Y. Wang Anti-inflammatory effect of lucidone in mice via inhibition of NF-kappaB/MAP kinase pathway International Immunopharmacology 10 2010 385 392
18. K.J. Senthil Kumar, J.W. Liao, J.H. Xiao, M. Gokila Vani, and S.Y. Wang Hepatoprotective effect of lucidone against alcohol-induced oxidative stress in human hepatic HepG2 cells through the up-regulation of HO-1/Nrf-2 antioxidant genes Toxicology In Vitro 26 2012 700 708
19. W. Shao, Z. Yu, Y. Chiang, Y. Yang, T. Chai, W. Foltz, H. Lu, I.G. Fantus, and T. Jin Curcumin prevents high fat diet induced insulin resistance and obesity via attenuating lipogenesis in liver and inflammatory pathway in adipocytes PLoS ONE 7 2012 e28784
20. P. Tontonoz, and B.M. Spiegelman Fat and beyond: the diverse biology of PPARgamma Annual Review of Biochemistry 77 2008 289 312
21. S.Y. Wang, X.Y. Lan, J.H. Xiao, J.C. Yang, Y.T. Kao, and S.T. Chang Antiinflammatory activity of Lindera erythrocarpa fruits Phytotherapy Research: PTR 22 2008 213 216
22. P.W. Wilson, R.B. D'Agostino, D. Levy, A.M. Belanger, H. Silbershatz, and W.B. Kannel Prediction of coronary heart disease using risk factor categories Circulation 97 1998 1837 1847
23. W. Xie, D. Gu, J. Li, K. Cui, and Y. Zhang Effects and action mechanisms of berberine and Rhizoma coptidis on gut microbes and obesity in high-fat diet-fed C57BL/6J mice PLoS ONE 6 2011 e24520
24. T. Yamauchi, J. Kamon, H. Waki, K. Murakami, K. Motojima, K. Komeda, T. Ide, N. Kubota, Y. Terauchi, K. Tobe, H. Miki, A. Tsuchida, Y. Akanuma, R. Nagai, S. Kimura, and T. Kadowaki The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance The Journal of Biological Chemistry 276 2001 41245 41254